Why did Trump's tariffs push some companies closer to default?
How will Union Pacific's potential Norfolk Southern merger impact railroads?
What caused Netflix's latest earnings surge despite stock dip?
Why is Coca-Cola considering cane sugar over corn syrup?
How does the GENIUS Act affect cryptocurrency regulation?
What are the risks if Trump fires Fed Chair Powell?
Why did Meta settle the $8 billion Facebook privacy lawsuit?
Sarepta Therapeutics' Reorganization Boosts Investor Confidence
benzinga.com/news/fda/25/07/46473418/sarepta-therapeutics-reorganization-boosts-investor-confidence
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) stock is trading higher on Thursday after the company issued an after-hours update on ongoing label expansion efforts for Elevidys, its approved gene therapy for Duchenne muscular dystrophy.
The U.S Food and Drug Administration (FDA) has requested…
This story appeared on benzinga.com, 2025-07-17 16:10:56.